Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Burkitt Lymphoma
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Non-Hodgkin’s Lymphoma (1038
)
Diffuse Large B Cell Lymphoma (364
)
Mantle Cell Lymphoma (126
)
T Cell Non-Hodgkin Lymphoma (118
)
Small Lymphocytic Lymphoma (106
)
Follicular Lymphoma (85
)
Peripheral T-cell Lymphoma (71
)
Lymphoplasmacytic Lymphoma (64
)
Marginal Zone Lymphoma (41
)
Cutaneous T-cell Lymphoma (19
)
Mediastinal B Cell Lymphoma (10
)
Non-Hodgkin’s Lymphoma (1038
)
Diffuse Large B Cell Lymphoma (364
)
Mantle Cell Lymphoma (126
)
T Cell Non-Hodgkin Lymphoma (118
)
Small Lymphocytic Lymphoma (106
)
Follicular Lymphoma (85
)
Peripheral T-cell Lymphoma (71
)
Lymphoplasmacytic Lymphoma (64
)
Marginal Zone Lymphoma (41
)
Cutaneous T-cell Lymphoma (19
)
Mediastinal B Cell Lymphoma (10
)
›
Associations
(20)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Burkitt Lymphoma
No biomarker
Burkitt Lymphoma
cyclophosphamide
Sensitive: A1 - Approval
cyclophosphamide
Sensitive
:
A1
cyclophosphamide
Sensitive: A1 - Approval
cyclophosphamide
Sensitive
:
A1
No biomarker
Burkitt Lymphoma
No biomarker
Burkitt Lymphoma
rituximab
Sensitive: A1 - Approval
rituximab
Sensitive
:
A1
rituximab
Sensitive: A1 - Approval
rituximab
Sensitive
:
A1
CD20 positive
Burkitt Lymphoma
CD20 positive
Burkitt Lymphoma
rituximab
Sensitive: A1 - Approval
rituximab
Sensitive
:
A1
rituximab
Sensitive: A1 - Approval
rituximab
Sensitive
:
A1
No biomarker
Burkitt Lymphoma
No biomarker
Burkitt Lymphoma
rituximab
Sensitive: A2 - Guideline
rituximab
Sensitive
:
A2
rituximab
Sensitive: A2 - Guideline
rituximab
Sensitive
:
A2
No biomarker
Burkitt Lymphoma
No biomarker
Burkitt Lymphoma
Sensitive: A2 - Guideline
Sensitive
:
A2
Sensitive: A2 - Guideline
Sensitive
:
A2
No biomarker
Burkitt Lymphoma
No biomarker
Burkitt Lymphoma
cytarabine + methotrexate
Sensitive: A2 - Guideline
cytarabine + methotrexate
Sensitive
:
A2
cytarabine + methotrexate
Sensitive: A2 - Guideline
cytarabine + methotrexate
Sensitive
:
A2
No biomarker
Burkitt Lymphoma
No biomarker
Burkitt Lymphoma
Sensitive: A2 - Guideline
Sensitive
:
A2
Sensitive: A2 - Guideline
Sensitive
:
A2
No biomarker
Burkitt Lymphoma
No biomarker
Burkitt Lymphoma
Sensitive: A2 - Guideline
Sensitive
:
A2
Sensitive: A2 - Guideline
Sensitive
:
A2
No biomarker
Burkitt Lymphoma
No biomarker
Burkitt Lymphoma
Sensitive: A2 - Guideline
Sensitive
:
A2
Sensitive: A2 - Guideline
Sensitive
:
A2
No biomarker
Burkitt Lymphoma
No biomarker
Burkitt Lymphoma
methotrexate
Sensitive: A2 - Guideline
methotrexate
Sensitive
:
A2
methotrexate
Sensitive: A2 - Guideline
methotrexate
Sensitive
:
A2
No biomarker
Burkitt Lymphoma
No biomarker
Burkitt Lymphoma
Sensitive: A2 - Guideline
Sensitive
:
A2
Sensitive: A2 - Guideline
Sensitive
:
A2
No biomarker
Burkitt Lymphoma
No biomarker
Burkitt Lymphoma
methotrexate
Sensitive: A2 - Guideline
methotrexate
Sensitive
:
A2
methotrexate
Sensitive: A2 - Guideline
methotrexate
Sensitive
:
A2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.